LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article: A rapid method to determine plasma homocysteine concentration and enrichment by gas chromatography/mass spectrometry.

    Valerio, Anna / Baldo, Goretta / Tessari, Paolo

    Rapid communications in mass spectrometry : RCM

    2005  Volume 19, Issue 4, Page(s) 561–567

    Abstract: Homocysteine is an independent risk factor for cardio- and/or cerebrovascular diseases. Many methods are used to measure plasma homocysteine levels in physiological fluids. Current gas chromatographic/mass spectrometric (GC/MS) methods allow ... ...

    Abstract Homocysteine is an independent risk factor for cardio- and/or cerebrovascular diseases. Many methods are used to measure plasma homocysteine levels in physiological fluids. Current gas chromatographic/mass spectrometric (GC/MS) methods allow determination not only of plasma homocysteine concentration, but also of its turnover. However, they have some methodological limitations due to the reduction of disulfide bonds between homocysteine and other thiols or proteins often requiring the use of several very toxic compounds or multi-step procedures that are particularly time-consuming, and/or utilize expensive instruments. Herein is described a rapid and precise GS/MS method to determine homocysteine turnover from a relatively low volume of plasma (200 microL). First disulfide bonds were reduced by 2-mercaptoethanol, which allows the maintenance of the reduced status preventing the rebuilding of the disulfide bond. Then the sample was derivatized to form the bis-tert-butyldimethylsilyl derivative. A deuterated internal standard, DL-[3,3,3',3',4,4,4',4'-2H8]-homocystine, was employed to account for losses associated with each analytical step. To evaluate the 'in vivo' homocysteine metabolic turnover, [1-13C]-methionine was infused and the derived [1-13C]-homocysteine quantitated. So a standard curve of [1-13C]-homocysteine was prepared by the decomposition of the [1-13C] methionine. The ions at m/z 325 and 326 were monitored, corresponding to the unlabeled [12C]-homocysteine and to labeled [13C]-homocysteine, respectively. The ion at m/z 325 ([M-114)]+) probably resulted from the loss of one derivatizing group to regenerate a free amino group. The intra-assay coefficient of variation (CV-intra%) was consistently less than 1.06%, the inter-assay (CV-inter%) less than 1.05%. The method described here seems to be simpler, more rapid, and less toxic than those published so far. In particular, its main strength appears to be the degree of precision obtained. We suggest applying this method to the measurement of the 'in vivo' rate of production of homocysteine (by the plasma 13C-homocysteine enrichment) from its precursor (13C-methionine).
    MeSH term(s) Gas Chromatography-Mass Spectrometry/methods ; Homocysteine/blood ; Homocysteine/chemistry ; Humans ; Mercaptoethanol/chemistry ; Reproducibility of Results
    Chemical Substances Homocysteine (0LVT1QZ0BA) ; Mercaptoethanol (60-24-2)
    Language English
    Publishing date 2005
    Publishing country England
    Document type Journal Article
    ZDB-ID 58731-x
    ISSN 1097-0231 ; 0951-4198
    ISSN (online) 1097-0231
    ISSN 0951-4198
    DOI 10.1002/rcm.1808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Different apoprotein(a) isoform proportions in serum and carotid plaque.

    Baldo, Goretta / Giunco, Silvia / Kontothanassis, Dimitrios / Baiocchi, Maria Rosa / Valerio, Anna / Frego, Mauro

    Atherosclerosis

    2007  Volume 193, Issue 1, Page(s) 177–185

    Abstract: Introduction: Cardio- and/or cerebro-vascular risk are associated with high lipoprotein (a) [Lp(a)] levels and low-molecular-weight (LMW) apo(a) isoforms. Aims of this study were to evaluate the deposition of apo(a) isoforms and apoprotein B (apo B) in ... ...

    Abstract Introduction: Cardio- and/or cerebro-vascular risk are associated with high lipoprotein (a) [Lp(a)] levels and low-molecular-weight (LMW) apo(a) isoforms. Aims of this study were to evaluate the deposition of apo(a) isoforms and apoprotein B (apo B) in atherosclerotic plaque from patients (males and females) who had carotid endarterectomy for severe stenosis, and to identify differences between patients classified by gender and divided according to the stability or instability of their plaques.
    Materials and methods: We determined lipids, apo B and Lp(a) in serum and plaque extracts from 55 males and 25 females. Apo(a) was phenotyped and isoforms were classified by number of kringle IV (KIV) repeats.
    Results: Lp(a) levels were higher in female serum and plaque extracts than in male samples, while apo B levels were lower. More Lp(a) than apo B deposition was observed in plaque after normalization for serum levels. Thirty-one different apo(a) isoforms were detected in our patients, with a double band phenotype in 94% of cases. In both sexes, the low/high (L/H) molecular weight apo(a) isoform expression ratio was significantly higher in plaque than in serum. Females with unstable plaques had higher Lp(a) levels in both serum and tissue extracts, and fewer KIV repeats of the principal apo(a) isoform in the serum than the other female group or males.
    Conclusions: In both sexes, the same apo(a) isoforms are found in serum and atherosclerotic plaque, but in different proportions: in plaque, LMW apo(a) is almost always more strongly accumulated than HMW apo(a), irrespective of any combination of apo(a) isoforms in double band phenotypes or Lp(a) serum levels. Moreover, serum and tissue Lp(a) levels were higher in females than in males, and particularly in the group with unstable plaques.
    MeSH term(s) Aged ; Apoprotein(a)/blood ; Apoprotein(a)/chemistry ; Apoprotein(a)/metabolism ; Carotid Stenosis/metabolism ; Carotid Stenosis/surgery ; Endarterectomy, Carotid ; Female ; Humans ; Kringles ; Lipid Metabolism ; Lipids/blood ; Lipoprotein(a)/blood ; Lipoprotein(a)/metabolism ; Male ; Middle Aged ; Protein Isoforms/blood ; Protein Isoforms/chemistry ; Protein Isoforms/metabolism ; Sex Characteristics
    Chemical Substances Lipids ; Lipoprotein(a) ; Protein Isoforms ; Apoprotein(a) (EC 3.4.21.-)
    Language English
    Publishing date 2007-07
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 80061-2
    ISSN 1879-1484 ; 0021-9150
    ISSN (online) 1879-1484
    ISSN 0021-9150
    DOI 10.1016/j.atherosclerosis.2006.06.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: False-positive troponin I attributed to a macrocomplex.

    Plebani, Mario / Mion, Monica / Altinier, Sara / Girotto, Maria Antonia / Baldo, Goretta / Zaninotto, Martina

    Clinical chemistry

    2002  Volume 48, Issue 4, Page(s) 677–679

    MeSH term(s) Aged ; Antigen-Antibody Complex ; False Positive Reactions ; Female ; Humans ; Sensitivity and Specificity ; Troponin I/blood ; Troponin I/immunology
    Chemical Substances Antigen-Antibody Complex ; Troponin I
    Language English
    Publishing date 2002
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 80102-1
    ISSN 1530-8561 ; 0009-9147
    ISSN (online) 1530-8561
    ISSN 0009-9147
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?

    Basso, Daniela / Greco, Eliana / Fogar, Paola / Pucci, Piero / Flagiello, Angela / Baldo, Goretta / Giunco, Silvia / Valerio, Anna / Navaglia, Filippo / Zambon, Carlo-Federico / Falda, Alessandra / Pedrazzoli, Sergio / Plebani, Mario

    Clinica chimica acta; international journal of clinical chemistry

    2006  Volume 372, Issue 1-2, Page(s) 120–128

    Abstract: Background: Our aim was to identify the pancreatic cancer diabetogenic peptide.: Methods: Pancreatic tumor samples from patients with (n=15) or without (n=7) diabetes were compared with 6 non-neoplastic pancreas samples using SDS-PAGE.: Results: A ...

    Abstract Background: Our aim was to identify the pancreatic cancer diabetogenic peptide.
    Methods: Pancreatic tumor samples from patients with (n=15) or without (n=7) diabetes were compared with 6 non-neoplastic pancreas samples using SDS-PAGE.
    Results: A band measuring approximately 1500 Da was detected in tumors from diabetics, but not in neoplastic samples from non-diabetics or samples from non-neoplastic subjects. Sequence analysis revealed a 14 amino acid peptide (1589.88 Da), corresponding to the N-terminal of the S100A8. At 50 nmol/L and 2 mmol/L, this peptide significantly reduced glucose consumption and lactate production by cultured C(2)C(12) myoblasts. The 14 amino acid peptide caused a lack of myotubular differentiation, the presence of polynucleated cells and caspase-3 activation.
    Conclusions: The 14 amino acid peptide from S100A8 impairs the catabolism of glucose by myoblasts in vitro and may cause hyperglycemia in vivo. Its identification in biological fluids might be helpful in diagnosing pancreatic cancer in patients with recent onset diabetes mellitus.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Cell Line, Tumor ; Diabetes Mellitus/etiology ; Female ; Humans ; Male ; Middle Aged ; Pancreatic Neoplasms/chemistry ; S100 Proteins/chemistry ; S100 Proteins/physiology ; Spectrometry, Mass, Electrospray Ionization
    Chemical Substances S-100A8 N-terminal peptide, human ; S100 Proteins
    Language English
    Publishing date 2006-10
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cca.2006.03.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications.

    Basso, Daniela / Greco, Eliana / Fogar, Paola / Pucci, Piero / Flagiello, Angela / Baldo, Goretta / Giunco, Silvia / Valerio, Anna / Navaglia, Filippo / Zambon, Carlo-Federico / Pedrazzoli, Sergio / Plebani, Mario

    Clinica chimica acta; international journal of clinical chemistry

    2005  Volume 357, Issue 2, Page(s) 184–189

    Abstract: Background: Diabetes mellitus is associated with pancreatic cancer in more than 80% of the cases. Clinical, epidemiological, and experimental data indicate that pancreatic cancer causes diabetes mellitus by releasing soluble mediators which interfere ... ...

    Abstract Background: Diabetes mellitus is associated with pancreatic cancer in more than 80% of the cases. Clinical, epidemiological, and experimental data indicate that pancreatic cancer causes diabetes mellitus by releasing soluble mediators which interfere with both beta-cell function and liver and muscle glucose metabolism.
    Methods: We analysed, by matrix-assisted laser desorption ionization time of flight (MALDI-TOF), a series of pancreatic cancer cell lines conditioned media, pancreatic cancer patients' peripheral and portal sera, comparing them with controls and chronic pancreatitis patients' sera.
    Results: MALDI-TOF analysis of pancreatic cancer cells conditioned media and patients' sera indicated a low molecular weight peptide to be the putative pancreatic cancer-associated diabetogenic factor. The sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of tumor samples from diabetic and non-diabetic patients revealed the presence of a 1500 Da peptide only in diabetic patients. The amino acid sequence of this peptide corresponded to the N-terminal of an S-100 calcium binding protein, which was therefore suggested to be the pancreatic cancer-associated diabetogenic factor.
    Conclusions: We identified a tumor-derived peptide of 14 amino acids sharing a 100% homology with an S-100 calcium binding protein, which is probably the pancreatic cancer-associated diabetogenic factor.
    MeSH term(s) Animals ; Diabetes Complications/diagnosis ; Diabetes Complications/etiology ; Diabetes Complications/genetics ; Diabetes Complications/metabolism ; Glucose/metabolism ; Humans ; Pancreatic Neoplasms/complications ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/metabolism ; Proteomics
    Chemical Substances Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2005-07-24
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cccn.2005.03.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top